184 related articles for article (PubMed ID: 9830391)
1. Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
Rogers R; Prpic R
Med J Aust; 1998 Oct; 169(8):425-7. PubMed ID: 9830391
[TBL] [Abstract][Full Text] [Related]
2. [Induction of bradycardia by mibefradil in antihypertensive combination therapy].
Wagner J; Ritz E
Dtsch Med Wochenschr; 1998 Apr; 123(17):547. PubMed ID: 9601479
[No Abstract] [Full Text] [Related]
3. The short life and rapid death of a novel antihypertensive and antianginal agent.
Krum H; McNeil JJ
Med J Aust; 1998 Oct; 169(8):408-9. PubMed ID: 9830386
[No Abstract] [Full Text] [Related]
4. Mibefradil, a pharmacologically distinct calcium antagonist.
Ernst ME; Kelly MW
Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
[TBL] [Abstract][Full Text] [Related]
5. Mibefradil--a new calcium-channel blocker.
Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500
[No Abstract] [Full Text] [Related]
6. The withdrawal of mibefradil (Posicor).
Griffin JP
Adverse Drug React Toxicol Rev; 1998; 17(2-3):59-60. PubMed ID: 9838964
[No Abstract] [Full Text] [Related]
7. Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
Alpert JS
Clin Cardiol; 1998 Feb; 21(2):129. PubMed ID: 9491954
[No Abstract] [Full Text] [Related]
8. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
Alpert JS; Kobrin I; DeQuattro V; Friedman R; Shepherd A; Fenster PE; Thadani U
Am J Cardiol; 1997 Apr; 79(8):1025-30. PubMed ID: 9114758
[TBL] [Abstract][Full Text] [Related]
9. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.
Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL
J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675
[TBL] [Abstract][Full Text] [Related]
10. Case report: rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatin.
Wombolt DG; Jackson A; Punn R; Smith S; McCune TR; Williams PB
J Clin Pharmacol; 1999 Mar; 39(3):310-2. PubMed ID: 10073331
[No Abstract] [Full Text] [Related]
11. Adding the new calcium antagonist mibefradil to patients receiving long-term beta-blocker therapy results in improved antianginal and antiischemic efficacy.
Schneeweiss A; Kobrin I; Charlon V; Caspi A; Marmor A; Sclarovsky S; Reisin L; Schlesinger Z
Am Heart J; 1998 Feb; 135(2 Pt 1):272-80. PubMed ID: 9489976
[TBL] [Abstract][Full Text] [Related]
12. Mibefradil (posicor).
Giles TD
Compr Ther; 1997 Nov; 23(11):761-3. PubMed ID: 9360806
[No Abstract] [Full Text] [Related]
13. Comment: mibefradil, a new class of calcium-channel antagonists.
Otterman S
Ann Pharmacother; 1998 Dec; 32(12):1372. PubMed ID: 9876826
[No Abstract] [Full Text] [Related]
14. Mibefradil: a new class of calcium-channel antagonists.
Billups SJ; Carter BL
Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
[TBL] [Abstract][Full Text] [Related]
15. What lessons can be learnt from withdrawal of mibefradil from the market?
Po AL; Zhang WY
Lancet; 1998 Jun; 351(9119):1829-30. PubMed ID: 9652662
[No Abstract] [Full Text] [Related]
16. Mibefradil withdrawn from the market.
Billups SJ; Carter BL
Ann Pharmacother; 1998; 32(7-8):841. PubMed ID: 9681103
[No Abstract] [Full Text] [Related]
17. Rhabdomyolysis due to interaction of simvastatin with mibefradil.
Schmassmann-Suhijar D; Bullingham R; Gasser R; Schmutz J; Haefeli WE
Lancet; 1998 Jun; 351(9120):1929-30. PubMed ID: 9654265
[No Abstract] [Full Text] [Related]
18. Withdrawal of Posicor from market.
SoRelle R
Circulation; 1998 Sep; 98(9):831-2. PubMed ID: 9738634
[No Abstract] [Full Text] [Related]
19. Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist.
Kobrin I; Charlon V; Lindberg E; Pordy R
Am J Cardiol; 1997 Aug; 80(4B):40C-46C. PubMed ID: 9286853
[TBL] [Abstract][Full Text] [Related]
20. [Current therapy of coronary heart disease. Conservative measures].
Stephan S
Internist (Berl); 1998 Sep; 39(9):1001-2. PubMed ID: 9788131
[No Abstract] [Full Text] [Related]
[Next] [New Search]